The effect of continuation of anti-platelet agents on bleeding complications after dento-alveolar surgical procedures.
Completed
- Conditions
- caries, parodontitis apicalis, adult parodon titis
- Registration Number
- NL-OMON22690
- Lead Sponsor
- Academic Medical Center, department of Oral Maxillofacial Surgery,Academic Medical Center, department of Internal Medicine
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 145
Inclusion Criteria
1. Patient on antiplatelet therapy who has to be treated in the AMC at the Department of Oral and Maxillofacial surgery;
2. Approval of the prescribing physician;
Exclusion Criteria
1. Known coagulation defect;
2. Use of oral anticoagulant treatment (vitamin K antagonists) or therapeutic heparin;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome of the study is peri-procedural blood loss.
- Secondary Outcome Measures
Name Time Method Secondary outcome is the occurrence of thrombo-embolic events at 30 days follow-up. The predictive effect of measurements in DNA, blood and saliva on peri-procedural hemostasis and blood loss is also a secondary endpoint.